BridgeBio Oncology Therapeutics, Inc. (BBOT)

NASDAQ: BBOT · Real-Time Price · USD

9.98

-0.14 (-1.38%)

At close: Feb 20, 2026, 4:00 PM EST

10.17

+0.19 (1.90%)

After-hours: Feb 20, 2026, 4:31 PM EST

BBOT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	798	247	-
Last Close Price	9.98	10.50	-
PB Ratio	1.77	1.71	-
Net Debt / Equity Ratio	-1.04	-1.07	0.02
Net Debt / EBITDA Ratio	3.75	1.93	0.00
Net Debt / FCF Ratio	5.34	2.83	0.01
Quick Ratio	13.12	7.95	0.12
Current Ratio	13.33	8.11	0.24
Return on Equity (ROE)	-	-110.95%	-
Return on Assets (ROA)	-	-59.37%	-
Return on Capital Employed (ROCE)	-27.70%	-55.90%	597.90%
Earnings Yield	-14.40%	-30.09%	-
FCF Yield	-10.93%	-22.31%	-
Buyback Yield / Dilution	-8840.04%	-16.36%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.